000 | 05402cam a2200577Ia 4500 | ||
---|---|---|---|
001 | ocn821115168 | ||
003 | OCoLC | ||
005 | 20221128212050.0 | ||
006 | m d | ||
007 | cr mn||||||||| | ||
008 | 121213s2013 si a ob 001 0 eng d | ||
040 |
_aHKP _beng _epn _cHKP _dOCLCO _dCDX _dYDXCP _dN$T _dOHS _dIDEBK _dE7B _dOCLCF _dDEBSZ _dOCLCQ _dOCLCO _dOCLCQ _dD6H _dAGLDB _dVGM _dOCLCQ _dUAB _dOCLCQ _dVTS _dTOF _dAU@ _dJBG _dWYU _dYOU _dREC _dSTF _dUKAHL _dOL$ _dOCLCO _dOCLCQ _dK6U _dLEAUB _dOCLCA _dOCLCO |
||
019 |
_a902865034 _a1086433884 |
||
020 |
_a9789814368674 _q(electronic bk.) |
||
020 |
_a9814368679 _q(electronic bk.) |
||
020 |
_z9789814368667 _q(print) |
||
020 | _z9814368660 | ||
035 |
_a516998 _b(N$T) |
||
035 |
_a(OCoLC)821115168 _z(OCoLC)902865034 _z(OCoLC)1086433884 |
||
060 | 4 | _aQV 778 | |
072 | 7 |
_aMED _x023000 _2bisacsh |
|
072 | 7 |
_aMED _x058170 _2bisacsh |
|
072 | 7 |
_aMED _x071000 _2bisacsh |
|
072 | 7 |
_aMED _x072000 _2bisacsh |
|
049 | _aMAIN | ||
245 | 0 | 0 |
_aNanopharmaceutics : _bthe potential application of nanomaterials _c _h[E-Book] |
260 |
_aSingapore : _bWorld Scientific Pub. Co., _c2013. |
||
300 |
_a1 online resource (ix, 594 pages) : _billustrations (some color) |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
504 | _aIncludes bibliographical references and index. | ||
520 | _aNanomaterials, with their unique size-dependent physical and chemical properties, have shown promising advantages as drug and gene delivery vehicles, ultra-sensitive intracellular detectors and novel therapeutic drugs. Nanopharmaceutics is one of the disciplines that will benefit the most from this technology. Nanotechnology will have a revolutionary impact on cancer diagnosis and therapy due to the exceptional characteristics of nanopharmaceutics. This book provides an overview of some tools, methods, and materials of nanotechnology that offer potential applications in pharmaceutics, followed by a series of examples showing applications that are already in development. It may very well inspire researchers to develop a new generation of pharmaceutics with inventive non-traditional approach and employ nanoscale science for the benefit of the patient. | ||
505 | 0 | _aCh. 1. Innovative treatments for cancer: the impact of delivering siRNAs, chemotherapies, and preventative agents using nanoformulations / Sara S. Hook [and others] -- ch. 2. Nano-emulsions: overview and applications / Xiang Li, Nicolas Anton and Thierry Vandamme -- ch. 3. Protein nanopharmaceuticals -- Concepts and safety considerations / Eva Horn Moller, Lene Jorgensen and Natalie J. Medlicott -- ch. 4. Nanoscaled proteomic analysis / Yan Xu and Lee Jia -- ch. 5. Tumor targeting potential of Lipid-Based Nano-Pharmaceuticals (LNPs) / Kshitij Gupta [and others] -- ch. 6. Novel methods of lipidic nanoparticle preparation and drug loading / Yoshie M. -- ch. 7. Biomedical properties study of modified chitosan nanoparticles for drug delivery systems / Mohammad Reza Saboktakin -- ch. 8. Dendrimers as nanovectors for nucleic acid delivery / Xiaoxuan Liu, Qi Wang, Ling Peng -- ch. 9. Drug delivery systems for platinum drugs / Vien T. Huynh, Wei Scarano, Martina H. Stenzel -- ch. 10. Improving platinum efficiency: nanoformulations / Rolando Carmona and Xing-Jie Liang -- ch. 11. Design principles of nanoparticles as contrast agents for magnetic resonance imaging / Liang Shan, Xinbin Gu, Paul Wang -- ch. 12. Perfluorocarbon nanoparticles: a theranostic platform technology / G.M. Lanza [and others] -- ch. 13. Potential toxic effects of nano-oxides / Mingsheng Xu [and others] -- ch. 14. Electron spin resonance spectroscopy for studying the generation and scavenging of reactive oxygen species by nanomaterials / Jun-Jie Yin [and others] -- ch. 15. Nanotechnology: a new approach to improve orthopedic implants / Hongjian Zhou, Fangfang Sun, Jaebeom Lee -- ch. 16. In situ controlled release of dopamine for treatment of Parkinson's Disease -- ch. 17. Novel nanotechnology strategies for the treatment and prevention of HIV infection / Jian Jun Tan [and others] -- ch. 18. Interaction of nanoparticles with the immune system and their significance in drug-design and development / Anil Kumar, Bhargavi M. Boruah and Xing-Jie Liang -- ch. 19. Nano-carbon-based systems for the delivery of bioactive agents: pros and cons / Tapas R. Nayak and Giorgia Pastorin -- ch. 20. Nanostructures with biocompatible and biodegradable characteristics / Jie Meng. | |
590 | _aWorldCat record variable field(s) change: 650 | ||
650 | 0 | _aNanomedicine. | |
650 | 0 | _aNanoparticles. | |
650 | 0 | _aNanotechnology. | |
650 | 2 | _aNanomedicine | |
650 | 2 | _aNanoparticles | |
700 | 1 | _aLiang, Xing-Jie. | |
856 | 4 | 0 |
_uhttps://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=516998 _yKingston Hospital NHS Foundation Trust OpenAthens account holders click here for access |
938 |
_aAskews and Holts Library Services _bASKH _nAH24926162 |
||
938 |
_aCoutts Information Services _bCOUT _n24464883 |
||
938 |
_aebrary _bEBRY _nebr10640618 |
||
938 |
_aEBSCOhost _bEBSC _n516998 |
||
938 |
_aProQuest MyiLibrary Digital eBook Collection _bIDEB _ncis24464883 |
||
938 |
_aYBP Library Services _bYANK _n9961400 |
||
942 | _n0 | ||
994 |
_a92 _bN$T |
||
999 |
_c90854 _d90854 |